Unique ID issued by UMIN | UMIN000019051 |
---|---|
Receipt number | R000022015 |
Scientific Title | Randomized, Placebo-controlled, Clinical Study to Investigate the Anti-Metabolic Syndrome Effect of the Functional Food in humans |
Date of disclosure of the study information | 2015/09/17 |
Last modified on | 2016/02/16 09:47:57 |
Randomized, Placebo-controlled, Clinical Study to Investigate the Anti-Metabolic Syndrome Effect of the Functional Food in humans
Box Lunch Study at Kanagawa Prefecture
Randomized, Placebo-controlled, Clinical Study to Investigate the Anti-Metabolic Syndrome Effect of the Functional Food in humans
Box Lunch Study at Kanagawa Prefecture
Japan |
Obesity
Medicine in general |
Others
NO
To investigate the effects of functional food on metabolic syndrome in obese subjects with visceral fat accumulation
Efficacy
Visceral fat area
After the administration after 6 weeks, the start of administration after 12 weeks
Interventional
Parallel
Randomized
Cluster
Open -but assessor(s) are blinded
Placebo
4
Treatment
Food |
The subjects take the test food(rice) during 12 weeks (non-holiday).
The subjects take the test food(Japanese tea) during 12 weeks (non-holiday).
The subjects take the test food(Side dish) during 12 weeks (non-holiday).
The subjects take the test food(rice,Japanese tea,Side dish) during 12 weeks (non-holiday).
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1) Aged 20-65 years at informed consent
2) Visceral fat area >=100cm2 for male, >=80cm2 for female
3) Body-mass index (BMI) 25-30 kg/m2 for male, 23-30 kg/m2 for female
4)Fasting blood glucose =<125mg/dL
5) Obtained written informed consent from the subjects for the study participation
1) Pregnancy, nursing or planning to become pregnant during the study (female only)
2) Any other significant medical conditions
3) Uncontrolled metabolic syndrome, or diabetes with insulin treatment
4) Severe allergies to wheat, soy, egg, milk, crustacean shellfish
5) Severe sensitivity to caffeine
6) Implantable electronic medical devices
7) Wearable electronic medical devices
8) Mechanical life support equipment
9) Metals as implantable materials
10) Dialysis patients
11) Participation in other clinical trials at enrollment
12) Any other considered by a study physician to be inappropriate for inclusion
160
1st name | |
Middle name | |
Last name | Shunichi Tanaka |
Medical Corporation Minato Mirai
President
2-2-1,minatoMirai,nisiku,Yokohama,Kanagawa,220-8139 Japan
045-640-1158
bento@crsu.org
1st name | |
Middle name | |
Last name | Hidekazu Saito |
Not-for profit Organization Japan Clinical Research Support Unit
Clinical Research Department
Yushima D&A Building 3F,1-10-5,yushima,bunkyou-ku,Tokyo,113-0034 Japan
03-5842-7480
bento@crsu.org
Not-for profit Organization Japan Clinical Research Support Unit
National Agriculture and Food Research Organization
Japan
Kanagawa Prefecture
NO
2015 | Year | 09 | Month | 17 | Day |
Unpublished
Completed
2015 | Year | 09 | Month | 01 | Day |
2015 | Year | 09 | Month | 09 | Day |
2015 | Year | 09 | Month | 17 | Day |
2016 | Year | 02 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022015